The American Society of Gene and Cell Therapy (ASGCT) Symposium: Immunologic Responses to Gene Therapy for Hemophilia

The American Society of Gene and Cell Therapy (ASGCT) Symposium: Immunologic Responses to Gene Therapy for Hemophilia

Chairs:
Federico Mingozzi, INSERM, Univ. of Pittsburgh Med. Ctr., Genethon
Roland W. Herzog, Univ. of Florida

Speakers:

• Roland W. Herzog, Univ. of Florida, In vivo gene therapy to induce immune tolerance in hemophilia
• Federico Mingozzi, INSERM, Univ. of Pittsburgh Med. Ctr., Genethon, Immune responses in clinical trials for hemophilia
• David W. Scott, Uniformed Services Univ., Regulatory T cell-mediated tolerance induction in hemophilia
• Antonia Follenzi, Univ. of Piemonte Orientale, microRNA-regulated lentiviral gene therapy for treatment and immune tolerance in hemophilia